Pharmacy in Cyprus and Malta: the 5.5-Year One

The two Cypriot programs are conventional: a single integrated master's degree over five years, the standard European structure.

Malta is structurally different and the fee table hides it. The University of Malta does not run a five-year integrated MPharm. It runs a four-year BSc (Hons) in Pharmaceutical Science, and you then progress to a three-semester MPharm. That is 5.5 years, in two stages, with a progression requirement between them.

The university publishes the arithmetic: EUR 10,800 per year for four years, then EUR 13,400 for the three-semester MPharm, for a pathway total of EUR 56,600. Quoting Malta as "EUR 10,800 a year" is technically true of the BSc stage and materially misleading about the degree.

For comparison across five years: European University Cyprus totals EUR 46,200 and the University of Nicosia EUR 54,000. So Malta is the most expensive of the three on the full pathway, and it also takes an extra half-year before you qualify.

The question to ask Malta in writing is what progression from the BSc to the MPharm actually requires. A two-stage pathway means there is a gate in the middle, and the consequences of not clearing it are different from failing a year of an integrated degree.

Both Cypriot universities admit on a rolling basis. European University Cyprus publishes no universal closing date and reviews applications while places remain; the University of Nicosia publishes no single closing date on the same basis.

European University Cyprus also runs two intakes: October 2026 and February 2027. Most European pharmacy programs run one intake a year, so if your documents or English test come through late, the cost is a few months rather than a full year. Riga Stradins does the same thing in dentistry, and it is rare enough in both fields to be worth knowing.

Rolling admission is genuinely convenient, and it has a trap in it. "While places remain" means the real deadline is the point at which the cohort fills, and that date is not published anywhere — it moves year to year and nobody tells you it has passed until you are told there is no place. Applying in month one and applying in month eight are not equivalent, even though the page gives you no reason to think otherwise.

Treat a rolling deadline as an early deadline. It is the opposite of what it looks like.

Malta publishes hard dates, and they are precise: 1 July 2026 at 14:00 for non-EU applicants requiring a visa, and a general deadline of 22 July 2026 at 14:00. Note the times. A 14:00 cutoff is not the end of the day, and we have written about deadlines that are a time and not a day because this catches people every year.

European University Cyprus is the most transparent of the three. It publishes a High School Leaving Certificate minimum of 17 out of 20, requires Biology and Chemistry, and states English at CEFR B2, IELTS 6.5 or above, or TOEFL iBT 79 or above. That is a complete, checkable specification, which is rarer than it should be.

Malta is specific in a different way. For the initial BSc stage it wants an international qualification equivalent to the university's general entry requirements, plus Advanced Level Chemistry at grade C or better and Pure Mathematics at Intermediate or Advanced Level. The mathematics requirement is the one to check early: it is not universal in European pharmacy admissions, and it is not something you can add late.

The University of Nicosia publishes no entry requirements that we could confirm. It states an academic file review and an interview or assessment under the integrated MPharm route, without grades or thresholds. Email and ask.

None of the three uses a standardized admissions test. There is no UCAT, no IMAT and no entrance examination of the kind Slovakia and Croatia run in dentistry — selection here is a file review, with an interview where the university wants one.

These are modeled planning estimates over a ten-month academic year, not quoted prices.

Both islands are relatively expensive to live in by continental standards. Nicosia models at about EUR 460 a month for housing and EUR 600 for living; Msida at EUR 500 and EUR 620. Compare that to EUR 240 a month for housing in Skopje, and the difference across five years is substantial.

Across the whole qualification, tuition plus modeled living comes to roughly EUR 100,700 at European University Cyprus and EUR 108,500 at the University of Nicosia over five years. Malta's 5.5-year pathway sits higher again on both lines.

If cost is the deciding factor, these three are not where the value is: the Western Balkans start at EUR 5,000 and Czechia and Slovakia sit at about EUR 7,500. What Cyprus and Malta offer instead is the next section.

This is the real argument for the region, and it applies unevenly across the three.

Malta states that English is the main teaching language, and that Maltese may be useful in local patient care. Malta and Ireland are the only EU countries where both the teaching and the working language of healthcare are English. Everywhere else in continental Europe, including Cyprus, you learn the local language for patient contact.

Cyprus does not get you that, despite teaching in English. European University Cyprus states that Greek is normally needed for local patient-facing practice, and the University of Nicosia that Greek may be required for local community and hospital placements and for Cyprus registration. If your plan involves practicing in Cyprus, Greek is part of it.

That distinction is worth money. If you intend to qualify and work inside the EU without learning a new language, Malta is one of two options and the other is Ireland, where pharmacy runs EUR 12,000 to EUR 25,000 a year. Malta's EUR 56,600 pathway total is well under five years at any Irish school.

Both countries are EU member states, so all three qualifications carry the automatic EU and EEA recognition route between member states.

For North America, all three are five years or more, which clears the US duration screen that the four-year British MPharm does not — that is the structural point our five-year rule guide sets out. Beyond duration, the United States and Canada run their own evaluation of any foreign pharmacy degree regardless of origin.

So: pick Cyprus for rolling admission, a February start and the cheapest fee of the three. Pick Malta if practicing in English inside the EU is the point — and go in knowing it is 5.5 years in two stages, EUR 56,600, with a progression gate in the middle that the annual fee does not tell you about.